135 related articles for article (PubMed ID: 34373022)
1. Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis.
Hu T; Zeng X; Tian T; Liu J
J Clin Neurosci; 2021 Sep; 91():159-171. PubMed ID: 34373022
[TBL] [Abstract][Full Text] [Related]
2. Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis.
Zhao GX; Shen ML; Zhang Z; Wang P; Xie CX; He GH
Int J Clin Pharm; 2019 Dec; 41(6):1414-1428. PubMed ID: 31650507
[TBL] [Abstract][Full Text] [Related]
3. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms of microsomal epoxide hydrolase and UDP-glucuronosyltransferase (UGT) and its effects on plasma carbamazepine levels and metabolic ratio in persons with epilepsy of South India: A cross-sectional genetic association study.
Venkatraman S; Ramasamy K; Nair PP
Indian J Pharmacol; 2023; 55(3):149-154. PubMed ID: 37555408
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
[TBL] [Abstract][Full Text] [Related]
6. Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis.
Fan YX; Zhang Z; Meng JR; Yin SJ; Wang P; Zhou T; Huang YH; Meng R; He GH
Epilepsy Res; 2021 Nov; 177():106785. PubMed ID: 34653781
[TBL] [Abstract][Full Text] [Related]
7. Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.
He XJ; Jian LY; He XL; Tang M; Wu Y; Xu YY; Sun XJ; Zhao LM
Epilepsia; 2014 Aug; 55(8):1301-6. PubMed ID: 24861996
[TBL] [Abstract][Full Text] [Related]
8. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y
Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961
[TBL] [Abstract][Full Text] [Related]
9. Influence of
Venkatraman S; Ramasamy K; Nair PP; Rajendran P
Drug Metab Pers Ther; 2023 Jun; 38(2):191-197. PubMed ID: 36853909
[TBL] [Abstract][Full Text] [Related]
10. Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.
Chbili C; Fathallah N; Laouani A; Nouira M; Hassine A; Ben Amor S; Ben Ammou S; Ben Salem C; Saguem S
J Neurogenet; 2016 Mar; 30(1):16-21. PubMed ID: 27276192
[TBL] [Abstract][Full Text] [Related]
11. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J
Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831
[TBL] [Abstract][Full Text] [Related]
12. Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Zhao GX; Zhang Z; Cai WK; Shen ML; Wang P; He GH
Epilepsy Res; 2021 Jul; 173():106615. PubMed ID: 33756436
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
[TBL] [Abstract][Full Text] [Related]
14. Effects of EPHX1 and CYP3A4 polymorphisms on carbamazepine metabolism in epileptic patients.
Caruso A; Bellia C; Pivetti A; Agnello L; Bazza F; Scazzone C; Bivona G; Lo Sasso B; Ciaccio M
Pharmgenomics Pers Med; 2014; 7():117-20. PubMed ID: 24817818
[TBL] [Abstract][Full Text] [Related]
15. Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population.
Lv Y; Zheng X; Shi M; Wang Z; Cui L
BMC Neurol; 2019 Jun; 19(1):114. PubMed ID: 31164100
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
17. Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.
Zhu X; Yun W; Sun X; Qiu F; Zhao L; Guo Y
Pharmacogenomics; 2014; 15(15):1867-79. PubMed ID: 25495409
[TBL] [Abstract][Full Text] [Related]
18.
Yang Q; Huang W; Yin D; Zhang L; Gao Y; Tong J; Li Z
Front Genet; 2023; 14():1128985. PubMed ID: 37284064
[No Abstract] [Full Text] [Related]
19. Association between EPHX1 rs1051740 and lung cancer susceptibility: a meta-analysis.
Zhang P; Zhang Y; Yang H; Li W; Chen X; Long F
Int J Clin Exp Med; 2015; 8(10):17941-9. PubMed ID: 26770388
[TBL] [Abstract][Full Text] [Related]
20. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy.
Ma CL; Jiao Z; Wu XY; Hong Z; Wu ZY; Zhong MK
Pharmacogenomics; 2015; 16(13):1499-512. PubMed ID: 26314341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
